Young, Diabetic, and at High CV Risk: Is It Time for Early Aspirin? Dr. Amit V. Joshi18 Aug 2025 11:47 AM ISTYoung, Diabetic, and at High CV Risk: A Case for Early CV Prevention with Aspirin in the High-Risk Young
Twelve Co-morbidities' Association and Risks Associated with Prediabetes-Evidence Every Clinician Must Know Dr. Ramdas Bharat Barure14 Aug 2025 10:50 AM ISTAugust 14 has been marked as World Prediabetes Day, set 90 days before World Diabetes Day (November 14), the typical timeframe needed to achieve a...
Heart Failure in Women: Updates from the National Consensus on Bisoprolol Dr. Prem Aggarwal13 Aug 2025 10:36 AM ISTHeart failure (HF) remains a significant cardiovascular public health concern in India, affecting an estimated 1.3 to 22.7 million people. The annual...
Dapagliflozin Reduces Heart Failure Risk After TAVI: Key Findings from the DapaTAVI Trial Deeksha Bhandari6 Aug 2025 8:30 AM ISTDapagliflozin significantly reduced the risk of all-cause mortality or worsening heart failure by 28% in high-risk patients undergoing transcatheter...
Addressing Ketoconazole Resistance: Exploring the Efficacy of Selenium Sulfide in Resistant Cases Dr. Kamal Kant Kohli5 Aug 2025 11:46 AM ISTSeborrheic dermatitis has long been treated with azoles, particularly ketoconazole, due to their effective antifungal and anti-inflammatory...
Penicillin-Binding Protein 3 Inserts in E.coli:A Growing Burden of Underreported Threat Dr. Kamal Kant Kohli31 July 2025 11:02 AM ISTIntroductionPenicillin-binding proteins (PBPs) synthesize and remodel the peptidoglycan layer of the bacterial cell wall, which maintain cell shape...
Management of Hypertension: How Innovative Packaging Can Improve Patient Outcomes? Dr. Garima Soni29 July 2025 12:00 PM ISTBurden of Hypertension in India and The Need for Educational Interventions With an estimated 315 million people affected by hypertension in...
Uncontrolled T2D in India: Valuable Consideration for Dapagliflozin Sitagliptin Combination Dr. D.C. Sharma25 July 2025 12:11 PM ISTIndia accounts for 1 in 7 adults living with diabetes globally. An estimated 89.8 million adults aged 20-79 years in India are living with diabetes,...
JAPI Releases Dedicated Supplement Addressing Clinical Needs for Adult Vaccination in India Dr. Bhumika Maikhuri18 July 2025 10:20 AM ISTDespite advancements in healthcare, pneumococcal disease continues to pose a serious and growing threat to adults in India, particularly those over...
Cuticapil Stem Hair Serum as Add-On to Minoxidil Shows Superior Hair Growth in Androgenetic Alopecia : Indian Real World Data Dr. Garima Soni17 July 2025 11:53 AM ISTIndia: An Indian real-world clinical study has demonstrated the efficacy and safety of Cuticapil Stem Hair Serum. When used alongside standard care...
Prediabetes and MASLD : An Overlapping Spectrum of Metabolic Risk Dr. Anusha N D14 July 2025 11:01 AM ISTConverging Burden of Prediabetes and MASLD: Prediabetes is associated with a nearly 4-fold higher risk of MASLD. (1) Approximately 33% of Indian...
Bisoprolol in CAD - Key Insights from National Consensus 2025 with Special Focus on Women Dr. Prem Aggarwal10 July 2025 11:39 AM ISTBisoprolol is reaffirmed as a key cardioselective Beta-1-blocker across the cardiovascular disease (CVD) continuum, with a special focus on its...
